References
- Das A, Martinez Santos JL, Alshareef M, Porto GBF, Infinger LK, Vandergrift WA, et al. In vitro effect of dovitinib (TKI258), a multi-target angiokinase inhibitor on aggressive meningioma cells . Cancer Invest. 2020;38(6):349–355. doi:https://doi.org/10.1080/07357907.2020.1773844.
- Das A, Alshareef M, Martinez Santos JL, Porto GBF, McDonald DG, Infinger LK, et al. Evaluating anti-tumor activity of palbociclib plus radiation in anaplastic and radiation-induced meningiomas: pre-clinical investigations. Clin Transl Oncol. 2020;22(11):2017–2025. doi:https://doi.org/10.1007/s12094-020-02341-7.
- Das A, Alshareef M, Henderson F, Martinez Santos JL, Vandergrift WA, Lindhorst SM, et al. Ganoderic acid A/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth. Clin Transl Oncol. 2020;22(7):1138–1145. doi:https://doi.org/10.1007/s12094-019-02240-6.
- Mei Y, Bi WL, Greenwald NF, Agar NY, Beroukhim R, Dunn GP, et al. Genomic profile of human meningioma cell lines. PLOS One. 2017;12(5):e0178322. doi:https://doi.org/10.1371/journal.pone.0178322.
- Batchu S. Caution using meningioma cell lines as tumour models. Cancer Invest. 2020;38(8–9):535–536. doi:https://doi.org/10.1080/07357907.2020.1821210.
- Ragel BT, Couldwell WT, Gillespie DL, Wendland MM, Whang K, Jensen RL. A comparison of the cell lines used in meningioma research. Surg Neurol. 2008;70(3):295–307. doi:https://doi.org/10.1016/j.surneu.2007.06.031.
- Kalamarides M, Peyre M, Giovannini M. Meningioma mouse models. J Neurooncol. 2010;99(3):325–331. doi:https://doi.org/10.1007/s11060-010-0331-5.